Stelmach; John E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stelmach; John E..The latest application filed is for "diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels".

Company Profile

3.15.13

Stelmach; John E. - Westfield NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels Grant 10,968,210 - Greshock , et al. April 6, 2	2021-04-06
Diamino-alkylamino-linked Arylsulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20200131167 - Greshock; Thomas J. ; et al.	2020-04-30
Soluble guanylate cyclase activators Grant 9,365,574 - Raghavan , et al. June 14, 2	2016-06-14
Soluble guanylate cyclase activators Grant 8,741,910 - Brockunier , et al. June 3, 2	2014-06-03
Glucagon receptor antagonist compounds Grant 8,445,538 - Lin , et al. May 21, 2	2013-05-21
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 8,436,015 - Lin , et al. May 7, 2	2013-05-07
Soluble Guanylate Cyclase Activators App 20130072492 - Raghavan; Subharekha ; et al.	2013-03-21
Substituted aryl and heteroaryl derivatives, compositions containing such compounds and methods of use Grant 8,318,760 - Stelmach , et al. November 27, 2	2012-11-27
Glucagon Receptor Antagonist Compounds App 20110251248 - Lin; Songnian ; et al.	2011-10-13
Soluble Guanylate Cyclase Activators App 20110218202 - Brockunier; Linda L. ; et al.	2011-09-08
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20110172256 - Lin; Songnian ; et al.	2011-07-14
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 7,968,589 - Stelmach , et al. June 28, 2	2011-06-28
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20100144824 - STELMACH; JOHN E. ; et al.	2010-06-10
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Grant 7,687,534 - Stelmach , et al. March 30, 2	2010-03-30
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use App 20100004158 - Stelmach; John E. ; et al.	2010-01-07
Substituted Aryl and Heteroaryl Derivatives, Compositions Containing Such Compounds and Methods of Use App 20080161347 - Stelmach; John E. ; et al.	2008-07-03
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use App 20080085926 - Stelmach; John E. ; et al.	2008-04-10
(Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents Grant 7,314,873 - Doherty , et al. January 1, 2	2008-01-01
Ophthalmic compositions for treating ocular hypertension App 20050256117 - Chen, Meng Hsin ; et al.	2005-11-17
(Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents App 20050176723 - Doherty, James B ; et al.	2005-08-11
(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents Grant 6,809,199 - Doherty , et al. October 26, 2	2004-10-26
(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents App 20030092712 - Doherty, James B. ; et al.	2003-05-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.